View Document Preview and Link
Open Document File Size: 2,20 MB Share Result on Facebook
City Rockville / Lincoln / / Company Immunex Corporation / QAS / Amgen / / Event FDA Phase / / Facility American College of Rheumatology / Rockville Pike / / IndustryTerm manufacturing / clinical protocols / / MedicalCondition tumor necrosis factor receptor / lymphoma / polyarticular-course juvenile rheumatoid arthritis / inflammatory processes / ankylosing spondylitis / RA psoriatic arthritis / arthritis / measures RA disease / rheumatoid arthritis / reported lymphomas / tumor necrosis factor / normal inflammatory and immune responses / inflammation / lymphoma incidence / / MedicalTreatment clinical protocols / / Organization Food and Drug Administration / New Drugs Center / Ph. Director Division / American College of Rheumatology / Center for Drug Evaluation and Research / DEPARTMENT OF HEALTH / office of Therapeutics Research / Center for Biologics Evaluation and Research / Pharmacokinetics After administration / / Person Marc Walton / Hunt / / Position Director / CLINICAL PHARMACOLOGY General / / Product SC / ENBREL / sulfasalazine / MTX tablets / Bacteriostatic Water for Injection / azathioprine / mannitol / Etanercept / II0 / / ProvinceOrState Maryland / Indiana / California / / Technology alpha / Pharmacokinetics / hybridization / http / html / recombinant DNA technology / PDF / / SocialTag